CBRE Group (CBRE)
NYSEReal EstateReal Estate ServicesSnapshot 2026-07-07
$143.79+2.31%
Close 2026-07-07 · 1-day change
Reading CBRE? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CBRE free→NYSEReal EstateReal Estate ServicesSnapshot 2026-07-07
Reading CBRE? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CBRE free→QuarterlyIQ Insights · CBRE
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 13 valuation methods, at three horizons. Current price $143.79. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $144 CBRE trades at 22× p/e, below its 25× p/e peer median, but our blended $128 fair value sits below the price. We hold it with low confidence: our number sits well below the analyst range and quality doesn't explain valuation multiples in this sub-industry, so the peer comparison is a weak guide. Analysts target $169–$179. Note: our $128 fair value sits below the entire analyst range ($169–$179). Even valued only for durable growth at sustainable margins, it's worth about $166 — above today's price, so the premium reflects that growth case, not pure multiple expansion. Not investment advice.
$169.00 – $179.00 (median $176.50) · 4 analysts · as of 2026-06-30
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $176.50 | — | — | Analyst | high |
| dcf fcfe | 12M | $32.54 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $14.90 | — | — | Hist. CAGR | high |
| graham number | 12M | $66.56 | — | — | TTM | high |
| Mgmt guidance | 12M | $188.97 | 24.5 | 7.70 | Mgmt | high |
| Peer EV/EBITDA | 12M | $130.71 | 19.4 | 7.84 | TTM | high |
| Peer P/FCF | 12M | $46.19 | 15.3 | 3.02 | TTM | high |
| Peer P/E | 12M | $161.98 | 24.5 | 6.60 | TTM | high |
| Peer P/S | 12M | $163.85 | 1.2 | 142.10 | TTM | high |
| PEG | 12M | $75.21 | 11.4 | 6.60 | TTM | high |
| residual income | 12M | $44.90 | — | — | TTM | high |
| Own P/E history | 12M | $135.08 | 20.5 | 6.60 | TTM | high |
| triangulated | 12M | $175.83 | 24.5 | 7.16 | Triangulated | high |
| Mgmt guidance | 3Y | $342.69 | 24.5 | 13.96 | Mgmt(prov.) | medium |
| Peer P/FCF | 3Y | $38.03 | 15.3 | 2.49 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $266.05 | 24.5 | 10.84 | Analyst | medium |
| Peer P/S | 3Y | $242.35 | 1.2 | 210.17 | Analyst | medium |
| PEG | 3Y | $123.54 | 11.4 | 10.84 | Analyst | medium |
| Own P/E history | 3Y | $221.88 | 20.5 | 10.84 | Analyst | medium |
| Mgmt guidance | 5Y | $509.60 | 24.5 | 20.76 | Mgmt(prov.) | high |
| Peer P/FCF | 5Y | $33.41 | 15.3 | 2.18 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $343.45 | 24.5 | 13.99 | Analyst | high |
| Peer P/S | 5Y | $312.85 | 1.2 | 271.31 | Analyst | high |
| PEG | 5Y | $159.48 | 11.4 | 13.99 | Analyst | high |
| Own P/E history | 5Y | $286.42 | 20.5 | 13.99 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.